Suppr超能文献

相似文献

1
Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2.
Appl Environ Microbiol. 2011 Feb;77(3):756-61. doi: 10.1128/AEM.01848-10. Epub 2010 Dec 10.
3
Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation.
Appl Environ Microbiol. 2014 Nov;80(21):6694-703. doi: 10.1128/AEM.01789-14. Epub 2014 Aug 22.
5
Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains.
Arch Virol. 2012 Feb;157(2):225-34. doi: 10.1007/s00705-011-1160-3. Epub 2011 Nov 2.
8
Phage sensitivity and prophage carriage in Staphylococcus aureus isolated from foods in Spain and New Zealand.
Int J Food Microbiol. 2016 Aug 2;230:16-20. doi: 10.1016/j.ijfoodmicro.2016.04.019. Epub 2016 Apr 16.
9
Genomic analysis of Staphylococcus phage Stau2 isolated from medical specimen.
Virus Genes. 2016 Feb;52(1):107-16. doi: 10.1007/s11262-015-1276-8. Epub 2015 Dec 26.

引用本文的文献

1
Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria.
Ther Adv Infect Dis. 2025 Jul 18;12:20499361251356057. doi: 10.1177/20499361251356057. eCollection 2025 Jan-Dec.
2
Frenemy: adaptive temperate phage_SAP_1432 supports survival in changing temperatures.
Microbiol Spectr. 2025 Jun 23:e0227124. doi: 10.1128/spectrum.02271-24.
3
In Vitro Activity of Bacteriophages Against Ocular Methicillin-resistant S. aureus Isolates Collected in the US.
Ophthalmol Ther. 2025 May;14(5):897-909. doi: 10.1007/s40123-025-01113-2. Epub 2025 Mar 12.
4
Lytic Spectra of Tailed Bacteriophages: A Systematic Review and Meta-Analysis.
Viruses. 2024 Dec 4;16(12):1879. doi: 10.3390/v16121879.
6
The host phylogeny determines viral infectivity and replication across Staphylococcus host species.
PLoS Pathog. 2023 Jun 8;19(6):e1011433. doi: 10.1371/journal.ppat.1011433. eCollection 2023 Jun.
7
The applications of animal models in phage therapy: An update.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2175519. doi: 10.1080/21645515.2023.2175519. Epub 2023 Mar 19.
8
The Combination of Salmonella Phage ST-3 and Antibiotics to Prevent Salmonella Typhimurium In Vitro.
Curr Microbiol. 2022 Oct 21;79(12):371. doi: 10.1007/s00284-022-03073-3.
9
Phage Therapy against : Selection and Optimization of Production Protocols of Novel Broad-Spectrum Phages.
Pharmaceutics. 2022 Sep 6;14(9):1885. doi: 10.3390/pharmaceutics14091885.
10
How Good are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections.
Infect Drug Resist. 2022 Feb 17;15:503-532. doi: 10.2147/IDR.S348700. eCollection 2022.

本文引用的文献

2
Isolation and characterization of a novel Enterococcus faecalis bacteriophage phiEF24C as a therapeutic candidate.
FEMS Microbiol Lett. 2008 Jan;278(2):200-6. doi: 10.1111/j.1574-6968.2007.00996.x.
3
Application of bacteriophages for detection and control of foodborne pathogens.
Appl Microbiol Biotechnol. 2007 Sep;76(3):513-9. doi: 10.1007/s00253-007-1031-8. Epub 2007 Jun 7.
4
Bacteria-eating virus approved as food additive.
FDA Consum. 2007 Jan-Feb;41(1):20-2.
5
Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice.
Antimicrob Agents Chemother. 2007 Feb;51(2):446-52. doi: 10.1128/AAC.00635-06. Epub 2006 Nov 20.
7
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Clin Microbiol Infect. 2006 Mar;12 Suppl 1:16-23. doi: 10.1111/j.1469-0691.2006.01344.x.
9
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.
J Infect Chemother. 2005 Oct;11(5):211-9. doi: 10.1007/s10156-005-0408-9.
10
Phage therapy: the Escherichia coli experience.
Microbiology (Reading). 2005 Jul;151(Pt 7):2133-2140. doi: 10.1099/mic.0.27849-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验